Your browser doesn't support javascript.
loading
General practitioners' attitude toward early and pre-dementia diagnosis of AD in five European countries-A MOPEAD project survey.
Sannemann, Lena; Müller, Theresa; Waterink, Lisa; Zwan, Marissa; Wimo, Anders; Stomrud, Erik; Pinó, Susana; Arrufat, Jordi; Rodríguez-Gomez, Octavio; Benaque, Alba; Bon, Jaka; Ferreira, Daniel; Johansson, Gunilla; Dron, Amanda; Dumas, Annette; Georges, Jean; Kramberger, Milica G; Visser, Pieter Jelle; Winblad, Bengt; Campo, Laura; Boada, Mercè; Jessen, Frank.
Afiliação
  • Sannemann L; Department of Psychiatry University of Cologne Faculty of Medicine and University Hospital Cologne Cologne Germany.
  • Müller T; Department of Psychiatry University of Cologne Faculty of Medicine and University Hospital Cologne Cologne Germany.
  • Waterink L; Department of Neurology Alzheimer Center Amsterdam, Amsterdam Neuroscience Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam the Netherlands.
  • Zwan M; Department of Neurology Alzheimer Center Amsterdam, Amsterdam Neuroscience Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam the Netherlands.
  • Wimo A; Department of Neurobiology Division of Neurogeriatrics, Care Sciences and Society, Karolinska Institutet Solna Sweden.
  • Stomrud E; Clinical Memory Research Unit Lund University Malmö Sweden.
  • Pinó S; Emmaboda Health Centre Region Kalmar County Emmaboda Sweden.
  • Arrufat J; Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades Universitat Internacional de Catalunya Barcelona Spain.
  • Rodríguez-Gomez O; EAP Sarrià-Vallvidrera-Les Planes Barcelona Spain.
  • Benaque A; Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades Universitat Internacional de Catalunya Barcelona Spain.
  • Bon J; Networking Research Center on Neurodegenerative Diseases (CIBERNED) Instituto de Salud Carlos III Madrid Spain.
  • Ferreira D; Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades Universitat Internacional de Catalunya Barcelona Spain.
  • Johansson G; Department of Neurology Center for Cognitive Impairments University Medical Center Ljubljana and Medical Faculty University of Ljubljana Ljubljana Slovenia.
  • Dron A; Department of Neurobiology Division of Clinical Geriatrics, Centre for Alzheimer Research, Care Sciences, and Society, Karolinska Institutet Huddinge Stockholm Sweden.
  • Dumas A; Department of Neurobiology Division of Neurogeriatrics, Care Sciences and Society, Karolinska Institutet Solna Sweden.
  • Georges J; Modus Research and Innovation Limited Dundee Technology Park Dundee UK.
  • Kramberger MG; ASDM Consulting Brussels Belgium.
  • Visser PJ; Alzheimer Europe Luxembourg Luxembourg.
  • Winblad B; Department of Neurology Center for Cognitive Impairments University Medical Center Ljubljana and Medical Faculty University of Ljubljana Ljubljana Slovenia.
  • Campo L; Department of Neurology Alzheimer Center Amsterdam, Amsterdam Neuroscience Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam the Netherlands.
  • Boada M; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience Maastricht University Maastricht the Netherlands.
  • Jessen F; Department of Neurobiology Division of Neurogeriatrics, Care Sciences and Society, Karolinska Institutet Solna Sweden.
Alzheimers Dement (Amst) ; 13(1): e12130, 2021.
Article em En | MEDLINE | ID: mdl-33665337
INTRODUCTION: General practitioners (GPs) play a key role in early identification of dementia, yet diagnosis is often missed or delayed in primary care. As part of the multinational Models of Patient Engagement for Alzheimer's Disease project, we assess GPs' attitude toward early and pre-dementia diagnosis of AD and explore barriers to early diagnosis. METHODS: Our survey covered general attitude toward early diagnosis, diagnostic procedures, resources, and opinion on present and future treatment options across five European countries. RESULTS: In total 343 GPs completed the survey; 74% of GPs indicated that an early diagnosis is valuable. There were country-specific differences in GPs' perceptions of reimbursement and time available for the patient. If a drug were available to slow down the progression of AD, 59% of the GPs would change their implementation of early diagnosis. DISCUSSION: Our findings provide insight into GPs' attitudes by exploring differences in perception and management of early diagnosis.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article